Windlas Biotech announced that it has received Good Manufacturing Practices (GMP) certification for its new State-of-the-Art Injectable facility from the Food Safety & Drugs Administration Authority of Uttarakhand, following the inspection in December 2024. The certification states, that the firm is following the Good Manufacturing Practices as per World Health Organization (WHO) TRS Guidelines.Powered by Capital Market - Live News

Net profit of Windlas Biotech rose 11.62% to Rs 15.66 crore in the quarter ended September 2024 as against Rs 14.03 crore during the previous quarter ended September 2023. Sales rose 22.49% to Rs 187.00 crore in the quarter ended September 2024 as against Rs 152.67 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales187.00152.67 22 OPM %12.3312.24 - PBDT26.7921.64 24 PBT20.2918.31 11 NP15.6614.03 12 Powered by Capital Market - Live News

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live News

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live News

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live News